Literature DB >> 14577073

Recurrent inflammatory pseudotumors in children.

Joseph S Janik1, Joseph P Janik, Mark A Lovell, Richard J Hendrickson, Denis D Bensard, Brian S Greffe.   

Abstract

BACKGROUND/
PURPOSE: pulmonary (PPT) and extrapulmonary pseudotumors (EPPT) are uncommon benign tumors, which, in general, do not recur after complete resection. Recurrence rates for both types of pseudotumors are undocumented in a large population of children, and the salient features of potential recurrences are unspecified.
METHODS: This is a report of 15 children with PPT and EPPT; 3 children had a recurrence. These pseudotumors recurred despite adequate primary resection of all gross disease at first presentation. The literature was reviewed to determine rate of recurrence for PPT and EPPT and also to document features common to recurrent pseudotumors.
RESULTS: Overall recurrence rate for pseudotumors was 14%. PPT and EPPT, which were not confined to a single organ, had a high chance of recurrence (46% and 30%, respectively) compared with PPT and EPPT, which were confined to a single organ (1.5% and 8%, respectively). Recurrences have appeared between 3 months and 7 years. Intraabdominal EPPT accounts for more than 75% of the EPPT recurrences.
CONCLUSIONS: PPT and EPPT recur more frequently than anticipated. All pseudotumors, which on initial presentation extend beyond the confines of a single organ, have a high chance of recurrence despite what appears to be adequate resection. Children with pseudotumors that extend beyond a single organ, require frequent postoperative evaluation for recurrence and may be candidates for chemotherapy or radiotherapy at the time of initial resection.

Entities:  

Mesh:

Year:  2003        PMID: 14577073     DOI: 10.1016/s0022-3468(03)00501-3

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  24 in total

1.  Inflammatory pseudotumour of the lung.

Authors:  Youri Kaitoukov; George Rakovich; Sylvain Trahan; Jocelyn Grégoire
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

Review 2.  ALK-immunoreactive neoplasms.

Authors:  Parham Minoo; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

3.  A Case of Rare Small Bowel Tumor in a Child and Review of Literature.

Authors:  J Deepak; K L Aravind; S Ramesh
Journal:  Indian J Surg Oncol       Date:  2015-06-03

4.  A case of pulmonary inflammatory pseudotumor: Recurrence appearing as several consolidative lesions after complete resection.

Authors:  Hong-Lyeol Lee; Lucia Kim; Kyung-Hee Lee; Kwang-Ho Kim; Cheol-Woo Kim
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

5.  Inflammatory myofibroblastic tumor of renal pelvis presenting with iterative hematuria and abdominal pain: A case report.

Authors:  Shuiqing Wu; Ran Xu; Huasheng Zhao; Xuan Zhu; Lei Zhang; Xiaokun Zhao
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 6.  Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor.

Authors:  Lillian M Lai; M Beth McCarville; Patricia Kirby; Simon C S Kao; Toshio Moritani; Eve Clark; Kousei Ishigami; Armita Bahrami; Yutaka Sato
Journal:  Pediatr Radiol       Date:  2015-05-12

7.  Inflammatory myofibroblastic tumor of the abdominal wall simulating rhabdomyosarcoma: report of a case.

Authors:  Akshay Pratap; Awadhesh Tiwari; Bikash Agarwal; Sagar Raj Pandey; Gunraj Paudel; Anand Kumar
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

Review 8.  A successfully treated inflammatory myofibroblastic tumor of the mandible with long-term follow-up and review of the literature.

Authors:  Takafumi Satomi; Masato Watanabe; Jun Matsubayashi; Toshitaka Nagao; Hiroshige Chiba
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

9.  Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center.

Authors:  Zuopeng Wang; Xiaolong Zhao; Kai Li; Wei Yao; Kuiran Dong; Xianmin Xiao; Shan Zheng
Journal:  Pediatr Surg Int       Date:  2015-11-21       Impact factor: 1.827

10.  Pulmonary inflammatory myofibroblastic tumour after Hodgkin's lymphoma.

Authors:  Vesna Ilic; Vincent Dunet; Maja Beck-Popovic; Ariane Boubaker
Journal:  BMJ Case Rep       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.